|
ADAPY Adaptimmune Therapeutics PLC - ADR 1621227 |
| Balance Sheet |
|
Current Assets
|
$78,115,000.00 |
|
Assets
|
$130,633,000.00 |
|
Current Liabilities
|
$51,513,000.00 |
|
Liabilities
|
$201,591,000.00 |
|
Equity
|
$-70,958,000.00 |
|
Shares Out
|
1590309546.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-101,372,000.00 |
|
Investing Cash Flow
|
$59,644,000.00 |
| Market Analysis |
Market Cap
|
$47,709,286.38 |
|
Price
|
$0.03 |
|
PB
|
0.14 |
|
EPS
|
-0.02 |
|
PS
|
1.16 |
|
FCF
|
$-102,650,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:00 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADAPY documents filed with the SEC.
ADAPY Filings
Clear
